Epratuzumab–SN-38: A New Antibody–Drug Conjugate for the Therapy of Hematologic Malignancies

Overview of attention for article published in Molecular Cancer Therapeutics, January 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user

patent: 103 patents

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 69 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,156 followers.

Emab-SN-38 is the new drug from Immunomedics http://t.co/Li0YHl76 another B-cell ADC with low tox profile - good in combo with veltuzumab?

Reply Repost Favourite